Published in Pain and Central Nervous System Week, June 7th, 2010
"Methods.- Adolescent migraineurs aged 12-17 years were enrolled in this 12-month, open-label study (Study ID CR002827). were instructed to record their assessments on paper headache records whenever they experienced a migraine headache that they treated with study medication. Safety was assessed descriptively and assessments included adverse event (AE) recording, change in laboratory values, vital signs,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pain and Central Nervous System Week